Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Cost of Revenue: 2012-2024

Historic Cost of Revenue for OptimizeRx (OPRX) over the last 13 years, with FY2024 value amounting to $32.7 million.

  • OptimizeRx's Cost of Revenue rose 876.37% to $8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.0 million, marking a year-over-year increase of 1517.1%. This contributed to the annual value of $32.7 million for FY2024, which is 1441.9% up from last year.
  • OptimizeRx's Cost of Revenue amounted to $32.7 million in FY2024, which was up 1441.9% from $28.6 million recorded in FY2023.
  • In the past 5 years, OptimizeRx's Cost of Revenue ranged from a high of $32.7 million in FY2024 and a low of $19.2 million during FY2020
  • Over the past 5 years, OptimizeRx's median Cost of Revenue value was $25.7 million (recorded in 2021), while the average stood at $25.9 million.
  • As far as peak fluctuations go, OptimizeRx's Cost of Revenue soared by 10972.3% in 2020, and later crashed by 846.27% in 2022.
  • Over the past 5 years, OptimizeRx's Cost of Revenue (Annual) stood at $19.2 million in 2020, then surged by 33.56% to $25.7 million in 2021, then dropped by 8.46% to $23.5 million in 2022, then rose by 21.88% to $28.6 million in 2023, then increased by 14.42% to $32.7 million in 2024.
  • Its Cost of Revenue stands at $32.7 million for FY2024, versus $28.6 million for FY2023 and $23.5 million for FY2022.